Drugs@FDA document

PONLIMSI Medication Guide · BLA 761385 SUPPL-6

Drugs@FDA document · TEVA PHARMACEUTICALS, INC. · Oct 6, 2026

Key facts

Drug name PONLIMSI
Document type Medication Guide
Application BLA761385
Submission SUPPL-6
Company TEVA PHARMACEUTICALS, INC.
Document date Oct 6, 2026
FDA document accessdata.fda.gov

At a glance

  • Labeling-Package Insert Document categories
  • 1–9 Documents for this application

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA documents

Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date:

Browse all Drugs@FDA documents